118 related articles for article (PubMed ID: 38670762)
21. A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol.
Struik GM; Godart J; Verduijn GM; Kolkman-Deurloo IK; de Vries KC; de Boer R; Koppert LB; Birnie E; Ghandi A; Klem TM; Pignol JP
Trials; 2018 Dec; 19(1):689. PubMed ID: 30558672
[TBL] [Abstract][Full Text] [Related]
22. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
23.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
24. A double-network poly(Nɛ-acryloyl L-lysine)/hyaluronic acid hydrogel as a mimic of the breast tumor microenvironment.
Xu W; Qian J; Zhang Y; Suo A; Cui N; Wang J; Yao Y; Wang H
Acta Biomater; 2016 Mar; 33():131-41. PubMed ID: 26805429
[TBL] [Abstract][Full Text] [Related]
25. Injectable hydrogel loaded with paclitaxel and epirubicin to prevent postoperative recurrence and metastasis of breast cancer.
Leng Q; Li Y; Zhou P; Xiong K; Lu Y; Cui Y; Wang B; Wu Z; Zhao L; Fu S
Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():112390. PubMed ID: 34579909
[TBL] [Abstract][Full Text] [Related]
26. Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
Baraya YS; Wong KK; Yaacob NS
J Ethnopharmacol; 2019 Apr; 233():13-21. PubMed ID: 30594607
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
28. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
Hiraga T; Williams PJ; Ueda A; Tamura D; Yoneda T
Clin Cancer Res; 2004 Jul; 10(13):4559-67. PubMed ID: 15240548
[TBL] [Abstract][Full Text] [Related]
29. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer.
Shahriari M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
Int J Pharm; 2019 Dec; 572():118835. PubMed ID: 31726198
[TBL] [Abstract][Full Text] [Related]
33. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
[TBL] [Abstract][Full Text] [Related]
34. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H
Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685
[TBL] [Abstract][Full Text] [Related]
35. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
Nie G; Cao X; Mao Y; Lv Z; Lv M; Wang Y; Wang H; Liu C
Int Immunopharmacol; 2021 Jun; 95():107153. PubMed ID: 33677254
[TBL] [Abstract][Full Text] [Related]
37. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
38. Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.
Vuong T; Mallet JF; Ouzounova M; Rahbar S; Hernandez-Vargas H; Herceg Z; Matar C
J Transl Med; 2016 Jan; 14():13. PubMed ID: 26762586
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
[TBL] [Abstract][Full Text] [Related]
40. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]